Success Metrics

Active Trials
2(67%)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_2
1
33%
Ph phase_4
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Recruiting1
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 21 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)

Trials by Status

recruiting133%
not_yet_recruiting133%
active_not_recruiting133%

Recent Activity

2 active trials
Showing 3 of 3
recruitingnot_applicable

Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer

NCT05937620
active_not_recruitingphase_2

Fluorescent Approach for Refined Endoscopic Marking With Clip Localization and Identification Procedure

NCT06714292
not_yet_recruitingphase_4

Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks

NCT06258486

Clinical Trials (3)

Showing 3 of 3 trials
NCT05937620Not Applicable

Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer

Recruiting
NCT06714292Phase 2

Fluorescent Approach for Refined Endoscopic Marking With Clip Localization and Identification Procedure

Active Not Recruiting
NCT06258486Phase 4

Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks

Not Yet Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3